Menu

Talis Biomedical Corporation TLIS

Full chart Compare
Set alert

Price alert · TLIS

All alert types
2.84 USD 0.00 (+0.00%)

Apr 1, 2026, 9:30 AM EDT

1.60 Day range 2.84

52-week range unavailable

YTD
0.00%
1 year
+71.08%

Revenue & Expenses

Other Income → Expenses: $4.81MExpenses → Selling, General & Admin: $28.21MExpenses → Research & Development: $40.69MGross Profit → Expenses: $2.09MRevenue → Gross Profit: $2.09MRevenue → Cost of Revenue: $41.00KNet Loss → Expenses: $62.01MOther Income$4.81MGross Profit$2.09MNet Loss$62.01MCost of Revenue$41.00KExpenses$68.91MSelling, General & Admin$28.21MResearch & Development$40.69MRevenue$2.13M

Latest period ending Dec 31, 2023 · select a line to chart its full history

TLIS annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
2.13M4.81M8.19M10.94M3.98M
2.09M-3.58M8.19M10.94M3.98M
-66.81M-115.14M-191.82M-91.18M-26.70M
-62.01M-113.01M-192.04M-91.13M-27.47M
-34.12-62.77-127.20-644.70-191.55
TLIS annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
76.73M130.19M232.54M173.13M21.60M
94.67M169.29M265.83M198.41M25.73M
25.56M42.55M31.85M16.03M4.12M
19.67M33.58M13.98M693.00K0
69.12M126.74M233.98M-108.57M-21.14M
TLIS annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-53.24M-100.14M-171.38M-87.02M-24.33M
-486.00K-1.61M-2.87M-8.20M-578.00K
33.00K406.00K234.43M246.75M39.61M
-486.00K-1.61M-2.87M-8.20M-578.00K
-53.69M-101.34M60.18M151.53M14.71M